Skip to content
NEWSnet Monterey
    • Homepage
Solenic Medical® Receives FDA IDE Approval to Initiate Pivotal Trial of SOLA-2™ for Periprosthetic Joint Infections

Author: Solenic Medical, Inc.

Posted Date:

June 23, 2026
  • Solenic Medical® Receives FDA IDE Approval to Initiate Pivotal Trial of SOLA-2™ for Periprosthetic Joint Infections

    Solenic Medical, Inc.
    June 23, 2026
  • Solenic Medical Announces Publication in Scientific Reports Demonstrating Enhanced Anti-Biofilm Activity Using Alternating Magnetic Fields

    Solenic Medical, Inc.
    February 26, 2026